Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00688168 · ClinicalTrials.gov registry record
Inflammatory Cytokines in Symptom Production in Multiple Myeloma
A clinical trial of Multiple Myeloma, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 491
- Enrollment target
- 1
- Study location
NCT00688168: Completed study of Multiple Myeloma, sponsored by M.D. Anderson Cancer Center.
NCT00688168 is a study of Multiple Myeloma that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 491 participants, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00688168, a study of Multiple Myeloma, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 491 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn about the pain and/or other symptoms that patients may experience either while you are being monitored by your doctor before a decision is made to start you on treatment for your MM, or during and after treatment for MM, and how these symptoms may affect therapy. A second goal is to learn how differences in genes may affect the symptom burden from cancer and cancer therapy.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Neurocognitive Testing
- BEHAVIORAL Neurosensory Testing
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 491 participants |
| Start Date | 2008-05-09 |
| Est. Completion | 2019-01-08 |
What the finished NCT00688168 record still lists
NCT00688168 is an observational study that tracks outcomes without assigning an intervention. The registered 491 participants enrollment target is mid-sized for trials with a published cap, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (10% lower).
The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire is the first listed.
NCT00688168 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00688168 about?
NCT00688168 is a clinical study titled "Inflammatory Cytokines in Symptom Production in Multiple Myeloma". The goal of this research study is to learn about the pain and/or other symptoms that patients may experience either while you are being monitored by your doctor before a decision is made to start you on treatment for your MM, or during and after treatment for MM, and how these symptoms may affect t...
What is the current status of trial NCT00688168?
This trial is currently completed. The enrollment target is 491 participants. The study started on 2008-05-09. Estimated completion is 2019-01-08.
What conditions does trial NCT00688168 study?
This clinical trial studies the following conditions: Multiple Myeloma.
What interventions are being tested in trial NCT00688168?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Neurocognitive Testing (BEHAVIORAL), Neurosensory Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00688168?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00688168 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00688168's enrollment target sits among peer trials
491 50th of 438 higher than 389 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03418961 · 491 participants · Phase 3
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- NCT05861973 · 492 participants · NA
SMARTer Weight Loss Management
- NCT05908331 · 492 participants · NA
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- NCT06953089 · 492 participants · Phase 2
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI